# |
PMID |
Sentence |
1 |
26384962
|
Previous reports from our lab had shown that some anti-purinergic receptor P2X4 antibodies cross-reacted with misfolded forms of mutant Cu/Zn superoxide dismutase 1 (SOD1), linked to amyotrophic lateral sclerosis (ALS).
|
2 |
26384962
|
Cross-reactivity could be caused by the abnormal exposure of an epitope located in the inner hydrophobic region of SOD1 that shared structural homology with the P2X4-immunizing peptide.
|
3 |
26384962
|
We had previously raised antibodies against human SOD1 epitope mimicked by the P2X4 immunizing peptide.
|
4 |
26384962
|
Previous reports from our lab had shown that some anti-purinergic receptor P2X4 antibodies cross-reacted with misfolded forms of mutant Cu/Zn superoxide dismutase 1 (SOD1), linked to amyotrophic lateral sclerosis (ALS).
|
5 |
26384962
|
Cross-reactivity could be caused by the abnormal exposure of an epitope located in the inner hydrophobic region of SOD1 that shared structural homology with the P2X4-immunizing peptide.
|
6 |
26384962
|
We had previously raised antibodies against human SOD1 epitope mimicked by the P2X4 immunizing peptide.
|
7 |
26384962
|
Previous reports from our lab had shown that some anti-purinergic receptor P2X4 antibodies cross-reacted with misfolded forms of mutant Cu/Zn superoxide dismutase 1 (SOD1), linked to amyotrophic lateral sclerosis (ALS).
|
8 |
26384962
|
Cross-reactivity could be caused by the abnormal exposure of an epitope located in the inner hydrophobic region of SOD1 that shared structural homology with the P2X4-immunizing peptide.
|
9 |
26384962
|
We had previously raised antibodies against human SOD1 epitope mimicked by the P2X4 immunizing peptide.
|